Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Obesity, dyslipidemia and cholesterol gallstone disease during one year of Antarctic residence.

Premkumar M, Sable T.

Rural Remote Health. 2012;12:2186. Epub 2012 Nov 17.

2.

Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease.

Cariati A, Piromalli E.

Expert Opin Pharmacother. 2012 Jun;13(9):1223-7. doi: 10.1517/14656566.2012.685161. Review.

PMID:
22607008
3.

Gallstone disease: Primary and secondary prevention.

Venneman NG, van Erpecum KJ.

Best Pract Res Clin Gastroenterol. 2006;20(6):1063-73. Review.

PMID:
17127188
4.

Cholelithiasis and cholecystitis.

Schirmer BD, Winters KL, Edlich RF.

J Long Term Eff Med Implants. 2005;15(3):329-38. Review.

PMID:
16022643
5.

Nutritional approaches to prevention and treatment of gallstones.

Gaby AR.

Altern Med Rev. 2009 Sep;14(3):258-67. Review.

6.

Contributions of obesity and weight loss to gallstone disease.

Everhart JE.

Ann Intern Med. 1993 Nov 15;119(10):1029-35. Review.

PMID:
8214980
7.
8.

Review: low caloric intake and gall-bladder motor function.

Festi D, Colecchia A, Larocca A, Villanova N, Mazzella G, Petroni ML, Romano F, Roda E.

Aliment Pharmacol Ther. 2000 May;14 Suppl 2:51-3. Review.

9.

A practical guide to the nonsurgical treatment of gallstones.

Maudgal DP, Northfield TC.

Drugs. 1991 Feb;41(2):185-92. Review.

PMID:
1709849
10.

Gallstones in obesity and weight loss.

Erlinger S.

Eur J Gastroenterol Hepatol. 2000 Dec;12(12):1347-52. Review.

PMID:
11192327
11.

Triglycerides and gallstone formation.

Smelt AH.

Clin Chim Acta. 2010 Nov 11;411(21-22):1625-31. doi: 10.1016/j.cca.2010.08.003. Epub 2010 Aug 10. Review.

PMID:
20699090
12.

Medical management of cholesterol gallstones.

Abate MA.

Drug Intell Clin Pharm. 1986 Feb;20(2):106-15. Review.

PMID:
3512222
13.
14.

Gallstone formation and weight loss.

Weinsier RL, Ullmann DO.

Obes Res. 1993 Jan;1(1):51-6. Review.

15.

Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed.

Guarino MP, Cocca S, Altomare A, Emerenziani S, Cicala M.

World J Gastroenterol. 2013 Aug 21;19(31):5029-34. doi: 10.3748/wjg.v19.i31.5029. Review.

16.

The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome.

Ahmed MH, Barakat S, Almobarak AO.

Ren Fail. 2014 Jul;36(6):957-62. doi: 10.3109/0886022X.2014.900424. Epub 2014 Mar 31. Review.

PMID:
24678942
17.

[Obesity and gallbladder diseases].

Jeong SU, Lee SK.

Korean J Gastroenterol. 2012 Jan;59(1):27-34. Review. Korean.

18.

Gallstones.

Njeze GE.

Niger J Surg. 2013 Jul;19(2):49-55. doi: 10.4103/1117-6806.119236. Review.

Supplemental Content

Support Center